Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
IDIQ 36C24823D0050 - 7 task orders is a federal award for 248-Network Contract Office 8 (36C248) held by Jubilant Draximage Radiopharmacies Inc. Estimated value $6.2M ($5M obligated). Current period of performance ends Sep 30, 2026.
Department of Veterans Affairs (VA) parent IDV 36C24823D0050 rolls up 7 task orders at 248-NETWORK CONTRACT OFFICE 8 (36C248). Cluster estimated value $6.2M; obligated $5.0M. Incumbents include JUBILANT DRAXIMAGE RADIOPHARMACIES INC..
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24823D0050?
36C24823D0050 (IDIQ 36c24823d0050 - 7 task orders) is a 248-Network Contract Office 8 (36C248) award with an estimated value of $6.2M, currently held by Jubilant Draximage Radiopharmacies Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C248-23-D-0050?
36C248-23-D-0050 is the dashed form of PIID 36C24823D0050 (IDIQ 36c24823d0050 - 7 task orders), held by Jubilant Draximage Radiopharmacies Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24823D0050?
248-Network Contract Office 8 (36C248) awarded 36C24823D0050 to Jubilant Draximage Radiopharmacies Inc.
Who is the incumbent on 36C24823D0050?
Jubilant Draximage Radiopharmacies Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Jubilant Draximage Radiopharmacies Inc’s 36C24823D0050 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.